Curis
CRIS
#11258
Rank
A$1.63 M
Marketcap
A$0.67
Share price
-13.73%
Change (1 day)
-70.51%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): A-$20.04

According to Curis's latest financial reports the company's current EPS (TTM) is A-$20.21. In 2025 the company made an earnings per share (EPS) of A-$33.85 an increase over its 2024 EPS that were of A-$199.86.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$20.04-40.8%
2025A-$33.85-83.07%
2024A-$199.86-22.15%
2023A-$256.72-26.17%
2022A-$347.7022.3%
2021A-$284.30-25.37%
2020A-$380.96-30.93%
2019A-$551.54-2.02%
2018A-$562.91
2016A-$1,279-10%
2015A-$1,421138.1%
2014A-$597.0340%
2013A-$426.45-25%
2012A-$568.6066.67%
2011A-$341.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.08-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.45-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.51-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$4.69-123.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$6.18-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$4.52-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$4.89-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA